In human ovarian carcinomas, there was a significant correlation between the expression of SIRT6 and active β-catenin, and their expression patterns were significantly associated with advanced clinicopathologic factors of ovarian carcinomas such as elevated serum level of CA125, higher tumor stage, and higher histologic grade. Here, SIRT6 is linked to ovarian carcinoma.